| 2024/07/16 08:00:00 | |
|---|---|
| Price | |
| 2,759.00 JPY | |
| Difference | 1.19% (32.50) |
General attributes
| ISIN | JP3546800008 |
| Symbol | 4543 |
| Exchange | Tokyo Stock Exchange |
| Currency | JPY |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 23,768 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | 2,750.00 JPY (1,600) |
| Ask (Ask size) | 2,759.50 JPY (300) |
| Open | 2,745.50 JPY |
| High | 2,779.50 JPY |
| Low | 2,740.00 JPY |
| Close (prev. day) | 2,726.50 JPY |
| VWAP | 2,759.5303 JPY |
| Volume (pcs) | 1,896,800 |
| Trading volume | 52,342,771.50 |
| Number of trades | 3,830 |
| Last size | 776,900 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: TERUMO CORP |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/16 08:00:00 | |
|---|---|
| Price | |
| 2,759.00 JPY | |
| Difference | 1.19% (32.50) |
General attributes
| ISIN | JP3546800008 |
| Symbol | 4543 |
| Exchange | Tokyo Stock Exchange |
| Currency | JPY |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 23,768 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | 2,750.00 JPY (1,600) |
| Ask (Ask size) | 2,759.50 JPY (300) |
| Open | 2,745.50 JPY |
| High | 2,779.50 JPY |
| Low | 2,740.00 JPY |
| Close (prev. day) | 2,726.50 JPY |
| VWAP | 2,759.5303 JPY |
| Volume (pcs) | 1,896,800 |
| Trading volume | 52,342,771.50 |
| Number of trades | 3,830 |
| Last size | 776,900 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +9.03% | +26.70% | +30.30% |
| Perf (abs.) | +228.50 | +581.50 | +641.50 |
| Beta | 0.91 | 0.97 | 0.99 |
| Volatility | 26.48 | 27.83 | 27.68 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2,771.38 JPY (3,295,580) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 2,671.24 JPY (3,439,947) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 2,714.10 JPY (3,560,815) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2,434.80 JPY (3,941,705) |
| YTD High | date | 3,014.50 JPY (2024/03/04) |
| YTD Low | date | 2,267.00 JPY (2024/01/04) |
| 52 Weeks High | date | 3,014.50 JPY (2024/03/04) |
| 52 Weeks Low | date | 1,856.00 JPY (2023/10/16) |
All listings for TERUMO CORP
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/07/16 | 08:09 | 15.80 EUR | 0.00 | 3 |
| Duesseldorf | 2024/07/16 | 19:31 | 15.70 EUR | 0.00 | 5 |
| FINRA other OTC Issues | 2024/07/16 | 17:20 | 17.092 USD | 0.02 | 17 |
| Frankfurt | 2024/07/16 | 08:02 | 15.90 EUR | 0.00 | 1 |
| Hanover | 2024/07/16 | 08:21 | 15.90 EUR | 0.00 | 1 |
| Munich | 2024/07/16 | 08:08 | 16.00 EUR | 0.00 | 1 |
| Stuttgart | 2024/07/16 | 08:04 | 15.80 EUR | 0.00 | 3 |
| Tokyo Stock Exchange | 2024/07/16 | 08:00 | 2,759.00 JPY | 52.34 | 3,830 |
| Tradegate | 2024/07/16 | 22:26 | 16.10 EUR | 0.00 | 1 |
Company Logo
Contact Details
| TERUMO CORP. |
| - - |
| 2-44-1 Hatagaya, Shibuya-Ku - 151-0072 Tokyo |
| Telefon: +81-3-3374-8111 |
| Fax: + |
| E-mail: kouhou_terumo01@terumo.co.jp |
PDF Downloads
| Company report: TERUMO CORP | |
Company Profile
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan. |
Members of Management Board
| Shinjiro Sato | Chairman of Managing Board |
| Antoinette Gawin | Member of Executive Committee |
| Fumihisa Hirose | Member of Executive Committee |
| Hiraku Samejima | Member of Executive Committee |
| Kazunori Hirose | Member of Executive Committee |
| Norimasa Kunimoto | Member of Executive Committee |
| Shoji Hatano | Member of Executive Committee |
| Toshiaki Takagi | Member of Executive Committee |
| Toshihiko Osada | Member of Executive Committee |
Board of directors
| Toshiaki Takagi | Chairman of Supervisory Board |
| Hidenori Nishi | Member of Supervisory Board |
| Keiya Ozawa | Member of Supervisory Board |
| Kyo Nishikawa | Member of Supervisory Board |
| Masaichi Nakamura | Member of Supervisory Board |
| Shinjiro Sato | Member of Supervisory Board |
| Shouji Hatano | Member of Supervisory Board |
| Soichiro Uno | Member of Supervisory Board |
| Takanori Shibazaki | Member of Supervisory Board |
| Yukiko Kuroda | Member of Supervisory Board |